Author:
Liu Jun,Wang Nian,Dang Hai-xia,Chen Bing-wei,Zhang Li,Zou Chong,Zhong Cheng-liang,Huang Ju-kai,Liu Qiong,Yu Ya-nan,Jiang Meng,Liang Wei-xiong,Chen Qi-guang,Wang Yong-yan,Shen Chun-ti,Wang Zhong,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference13 articles.
1. Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, et al. Data monitoring committees: promoting best practices to address emerging challenges. Clin Trials 2017;14:115–123.
2. Committee for Medicinal Products for Human Use; Efficacy Working Party; Committee for Release for Consultation. Committee for Medicinal Products for Human Use (CHMP) guideline on data monitoring committees. Stat Med 2006;25:1639–1645.
3. European Medicines Agency. Guideline on data monitoring committees 2005. Available at: http://www.emea.europa.eu/pdfs/human/ewp/587203en.pdf.
4. Food and Drug Administration. Guidance for clinical trial sponsors establishment and operation of clinical trial data monitoring committees 2006. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm127073.pdf.
5. Wang L, Liu J, Dang HX, Wang Z, & Shen CT. Data and safety monitoring of Danhong injection in W clinical trials. Journal of Chinese Pharmaceutical ences 2015;50:375–378.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献